This observation was further validated in a cohort of 20 primary and 18 metastatic PCa samples, where EHMT2 protein levels were significantly higher in metastatic tissues, whereas CLSTN2 expression remained largely unchanged (Figures 1E,F and S1B). The gene discussed is EHMT2; the disease is posterior cortical atrophy.